Plasma orexin concentrations in patients on hemodialysis. 2002

Taro Sugimoto, and Yoshio Nagake, and Shigeru Sugimoto, and Shigeru Akagi, and Haruo Ichikawa, and Yoshio Nakamura, and Norio Ogawa, and Hirofumi Makino
Department of Medicine and Clinical Science, Graduate School of Medicine and Dentistry, Okayama University, Japan.

BACKGROUND Orexins A and B are neuropeptides that regulate feeding behavior and are localized exclusively in neurons within and around the lateral hypothalamic area. Intracerebroventricular injection of orexin A stimulates food consumption in rats. Plasma concentrations of orexins may reflect nutritional states and may have clinical significance in patients on hemodialysis. In this study, we investigated the relationship between plasma orexin concentrations and nutritional states in patients on hemodialysis. METHODS We measured plasma orexin concentrations in patients on hemodialysis (HD group, n = 67), patients with IgA nephropathy (n = 10), patients with diabetes mellitus (n = 11) and healthy controls (n = 10). We examined the relationships between plasma orexin concentrations and nutritional indices. RESULTS Plasma orexin A concentrations were significantly higher in the HD group than in the control group and showed a significant correlation with serum creatinine. In all subjects, there was a positive correlation between the plasma orexin A concentration and the serum creatinine concentration, but there were no correlations between these concentrations in each group. In the HD group, plasma orexin A concentrations had a significant positive correlation with the serum albumin concentration and percent creatinine generation rate (%CGR). Multiple regression analysis demonstrated that %CGR was the only independent factor associated with plasma orexin A concentrations. CONCLUSIONS Plasma orexin A concentrations are increased in patients on hemodialysis. It is possible that the kidney plays a major role in the clearance of orexins. The plasma orexin A concentration is significantly correlated with %CGR, and it may be able to be used as a clinical marker of the nutritional state in patients on hemodialysis.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009479 Neuropeptides Peptides released by NEURONS as intercellular messengers. Many neuropeptides are also hormones released by non-neuronal cells. Neuropeptide
D009752 Nutritional Status State of the body in relation to the consumption and utilization of nutrients. Nutrition Status,Status, Nutrition,Status, Nutritional
D002352 Carrier Proteins Proteins that bind or transport specific substances in the blood, within the cell, or across cell membranes. Binding Proteins,Carrier Protein,Transport Protein,Transport Proteins,Binding Protein,Protein, Carrier,Proteins, Carrier
D003404 Creatinine Creatinine Sulfate Salt,Krebiozen,Salt, Creatinine Sulfate,Sulfate Salt, Creatinine
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D005260 Female Females
D005922 Glomerulonephritis, IGA A chronic form of glomerulonephritis characterized by deposits of predominantly IMMUNOGLOBULIN A in the mesangial area (GLOMERULAR MESANGIUM). Deposits of COMPLEMENT C3 and IMMUNOGLOBULIN G are also often found. Clinical features may progress from asymptomatic HEMATURIA to END-STAGE KIDNEY DISEASE. Berger Disease,Immunoglobulin A Nephropathy,Nephropathy, IGA,Berger's Disease,IGA Glomerulonephritis,IGA Nephropathy,Iga Nephropathy 1,Nephritis, IGA Type,Bergers Disease,Glomerulonephritides, IGA,IGA Type Nephritis,Nephropathy 1, Iga,Nephropathy, Immunoglobulin A
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses

Related Publications

Taro Sugimoto, and Yoshio Nagake, and Shigeru Sugimoto, and Shigeru Akagi, and Haruo Ichikawa, and Yoshio Nakamura, and Norio Ogawa, and Hirofumi Makino
April 1996, Research communications in molecular pathology and pharmacology,
Taro Sugimoto, and Yoshio Nagake, and Shigeru Sugimoto, and Shigeru Akagi, and Haruo Ichikawa, and Yoshio Nakamura, and Norio Ogawa, and Hirofumi Makino
April 2014, Scandinavian journal of clinical and laboratory investigation,
Taro Sugimoto, and Yoshio Nagake, and Shigeru Sugimoto, and Shigeru Akagi, and Haruo Ichikawa, and Yoshio Nakamura, and Norio Ogawa, and Hirofumi Makino
January 1987, Nephron,
Taro Sugimoto, and Yoshio Nagake, and Shigeru Sugimoto, and Shigeru Akagi, and Haruo Ichikawa, and Yoshio Nakamura, and Norio Ogawa, and Hirofumi Makino
January 2002, Experimental gerontology,
Taro Sugimoto, and Yoshio Nagake, and Shigeru Sugimoto, and Shigeru Akagi, and Haruo Ichikawa, and Yoshio Nakamura, and Norio Ogawa, and Hirofumi Makino
January 2008, International journal of immunopathology and pharmacology,
Taro Sugimoto, and Yoshio Nagake, and Shigeru Sugimoto, and Shigeru Akagi, and Haruo Ichikawa, and Yoshio Nakamura, and Norio Ogawa, and Hirofumi Makino
January 2002, The Annals of pharmacotherapy,
Taro Sugimoto, and Yoshio Nagake, and Shigeru Sugimoto, and Shigeru Akagi, and Haruo Ichikawa, and Yoshio Nakamura, and Norio Ogawa, and Hirofumi Makino
January 2012, Urologia internationalis,
Taro Sugimoto, and Yoshio Nagake, and Shigeru Sugimoto, and Shigeru Akagi, and Haruo Ichikawa, and Yoshio Nakamura, and Norio Ogawa, and Hirofumi Makino
March 1993, Masui. The Japanese journal of anesthesiology,
Taro Sugimoto, and Yoshio Nagake, and Shigeru Sugimoto, and Shigeru Akagi, and Haruo Ichikawa, and Yoshio Nakamura, and Norio Ogawa, and Hirofumi Makino
January 2007, Journal of biological regulators and homeostatic agents,
Taro Sugimoto, and Yoshio Nagake, and Shigeru Sugimoto, and Shigeru Akagi, and Haruo Ichikawa, and Yoshio Nakamura, and Norio Ogawa, and Hirofumi Makino
September 1998, Nephron,
Copied contents to your clipboard!